Earnings call transcript: SBC Medical Holdings beats EPS forecasts in Q4 2025

NodeGuardian · 2026-03-27T15:06:52+00:00

SBC Medical Holdings exceeded EPS expectations in Q4 2025 but fell short on revenue. Despite a yearly revenue decline, net income increased, boosting investor confidence and stock performance. The company aims to enhance its corporate wellness platform and expand globally using AI and M&A strategies.

NodeGuardian

2026-03-27 15:06:52

Abstract generation in progress

SBC Medical Holdings reported Q4 2025 EPS of $0.14, beating analyst forecasts of $0.11, but revenue of $39.57 million missed the anticipated $44.02 million. Despite a 15% year-over-year revenue decline due to restructuring, net income increased by 9% and EPS by 4% for the full year, driven by effective cost management. The company’s stock rose 1.32% in pre-market trading, reflecting investor confidence in its profitability, and plans to focus on its corporate wellness platform, SBC Wellness 2.0, and strategic global expansion, leveraging AI and M&A for future growth.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.